Structured Summary
Abstract
Immunoconjugate that consists of the chimeric monoclonal anti - CD30 ANTIGEN antibody cAC-10 conjugated to monomethyl auristatin E. It is used for the treatment of LYMPHOMA.
MeSH Record
Classification
Broader headings
Related Concepts
Knowledge Graph
Loading graph…
Drag nodes to rearrange; hover to trace links; click a node to open its page.
Drug Class
Pharmacological Action
MeSH Record
Synonyms
10 entry terms
- Adcetris
- CAC10-1006
- SGN-35
- cAC10-vcMMAE
- CAC10 1006
- CAC101006
- SGN 35
- SGN35
- cAC10 vcMMAE
- cAC10vcMMAE
MeSH Record
Aspects Covered
24 allowable subheadings
Indexed with the subheadings administration & dosage, adverse effects, analysis, biosynthesis, blood, cerebrospinal fluid, chemistry, classification, drug effects, economics, genetics, history, immunology, isolation & purification, metabolism, pharmacokinetics, pharmacology, physiology, poisoning, radiation effects, therapeutic use, toxicity, ultrastructure, urine.
MeSH Record
History Note
2020 (2010)
MeSH Hierarchy
Tree Numbers
AMA Style
References
- National Library of Medicine. Brentuximab Vedotin. Medical Subject Headings (MeSH). 2026. Unique ID D000079963. http://id.nlm.nih.gov/mesh/2026/D000079963
- Brentuximab Vedotin. In: Wikipedia. https://en.wikipedia.org/wiki/Brentuximab_vedotin
- Brentuximab Vedotin. In: Wikidata. https://www.wikidata.org/wiki/Q422324